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MCCB1 - GENETIC HYBRIDISATION IN TRYPANOSOMA CRUZI.
1Miles, M. A., 1Yeo, M., 1Frame, I. A., 2Stothard, J. R., 3Carrasco, H. J., 1Taylor, M. C., 1Solis Mena, S., 1Veazey,
P., 1Miles, G. A. J., 4Acosta, N., 4Rojas de Arias, A. and 1Gaunt , M. W.
1
 London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.2 The Natural
History Museum, London, UK. 3 Universidad Central de Venezuela, Caracas, Venezuela. 4 Universidad Nacional
de Asuncion, Asuncion, Paraguay.
The species T. cruzi is divided into 2 divisions (I and II) based on isoenzyme phenotypes, DNA
profiles, ribosomal and mini-exon DNA sequence polymorphisms, and microsatellite analysis.
Additionally, T. cruzi II, which predominates where Chagas disease is more severe, can be divided into
up to 5 sublineages (IIa-e). The presence of genetic exchange in T. cruzi, and in Leishmania, is much
debated. Recent phylogenetic and karyotype evidence suggests that T. cruzi IId and IIe may have an
ancient hybrid origin. However, population genetics has emphasised clonal propagation and the lack of
genetic exchange in T. cruzi when natural isolates, from dispersed geographical localities, were tested
for random mendelian genetic exchange.
As described in detail in Gaunt et al. (2003), a mechanisim is observed in T. cruzi that is distinct
from mendelian inheritance. A pair of putative parental biological clones of T. cruzi, transfected to
carry different drug resistance markers (hygromycin; neomycin), were passaged singly or together
through the various life cycle stages. Six, double drug resistant, biological clones, were recovered
from the mammalian stage of the life cycle. DNA amplification showed that the 6 clones contained
both the hyg and neo genes. Isoenzyme analysis and karyotype analysis showed that the clones shared
parental characters and were at least in part hybrids. Random amplification of polymorphic DNA
(RAPD) revealed characteristic sharing of bands between progeny clones and parents; controls with
non-transformed parents showed that shared bands were not attributable to the episomes. For a series
of informative microsatellite loci progeny clones showed all parental alleles, whereas for others absence
of alleles indicated allele loss. Sequence analysis of nuclear genes indicated fusion, recombination and
allele loss. Uniparental inheritance of mitochondrial maxicircle genotype was observed.
There are strong parallels between the experimental hybrids and the genotypes among natural
populations of T. cruzi, including the presence of polyploid genotypes. Phylogenetic analyses gave
unequivocal evidence of genetic recombination among natural populations and infers that the mechanism
spans far greater genetic distances than mendelian inheritance.
Aneuploidy via hybridisation explains the wide range in DNA content of T. cruzi, and reconciles the
paradox between apparent clonal propagation yet occurrence of recombination. Most importantly,
aneuploidy via nuclear hybridisation may lead to dramatic speciation events; it is also likely to be
present in Leishmania.
Financed primarily by the Wellcome Trust.
Gaunt G. W, Yeo M. , Frame I. A. , Stothard J. R. , Carrasco H. J. , Taylor M. C., Mena S. S., Veazey P., Miles G. A. J. , Acosta
N., Arias A. R. de, Miles M. A. (2003) Mechanism of genetic exchange in American trypanosomes. Nature; 421: 936-39.
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MCCB2 - N-MYRISTOYLATION AS A TARGET FOR INTERVENTION IN
KINETOPLASTID PARASITIC INFECTIONS
Smith D.F., Panethymitaki C., Price H.P., Mills E., Tempero J., Brown K.A.
Wellcome Trust Labs for Molecular Parasitology, Centre for Molecular Microbiology and Infection, Department
of Biological Sciences, Imperial College London, UK
Myristoyl CoA: protein N-myristoyltransferase (NMT) catalyses the transfer of the fatty acid,
myristate, to the N-terminal glycine of eukaryotic cellular and viral proteins and is essential for the
viability of Candida albicans, Cryptococcus neoformans and Saccharomyces cerevisiae. Selective and
specific inhibition of NMT activity in a range of pathogenic fungal species has confirmed a potential
role for this enzyme as a drug target in these organisms. To test whether NMT might also be a useful
target in kinetoplastid parasites, we are investigating NMT function in Leishmania species and
Trypanosoma brucei.
Myristic acid analogues, non-specific inhibitors of NMT, are toxic to Leishmania promastigotes
and bloodstream T. brucei, inhibiting the N-myristoylation of cellular proteins. The single copy L.
major NMT gene is constitutively-expressed during the parasite life cycle and encodes a 48 kDa protein
that is well-conserved in regions essential for myristoyl CoA and peptide substrate binding in S.
cerevisiae. Gene deletion experiments, targeting the removal of both NMT alleles by homologous
recombination coupled with functional complementation by episomal expression, have demonstrated
that NMT is essential for viability in Leishmania. Similarly, NMT over-expression causes gross changes
in Leishmania morphology, decreased growth rate and increased cell death. In T. brucei, RNA interference
assays have confirmed that NMT is also essential in this species.
Soluble active recombinant L. major and T. brucei NMTs have been produced in E. coli and are
being used in kinetic analyses to determine the K
m
 values for the myristoyl CoA and peptide substrates
and the inhibitory effects of lead compounds. We have already shown that peptidomimetic NMT
inhibitors active against fungal pathogens are highly toxic to bloodstream T. brucei. Comparative
sequence alignment and homology modeling based upon existing NMT crystal structures are in progress
to identify parasite-specific features of functional importance that can be exploited for the design of
selective inhibitors.
In order to identify the downstream targets that cause lethality in the absence of NMT activity, we
have searched the genomes of L. major and T. brucei for proteins carrying N-myristoylation motifs.
Several N-myristoylated proteins have been cloned and characterised, including ADP-ribosylation factor
(ARF) proteins, a Leishmania specific serine/threonine protein kinase and a novel serine/threonine
protein phosphatase present in both L. major and T. brucei. Genetic approaches are being used to
establish whether parasite death in NMT mutants and inhibitor-treated parasites is associated with
depletion of one or more of these proteins in vivo.
This work is supported by the Wellcome Trust and the Biotechnology and Biological Sciences
Research Council, UK.
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MCCT1 - DIAGNOSIS AND TREATMENT OF CHAGAS DISEASE AND
TOXOPLASMOSIS IN PEDIATRIC PATIENTS
Hector Freilij, Jaime Altcheh
Hospital de Niños Ricardo Gutierrez. Buenos Aires-Argentina - freilij@sinectis.com.ar
A) Chagas disease
The accurate diagnosis is made by T. cruzi detection in blood, in CSF or in tissues. If this is not
possible, diagnosis must be made through the study of specific antibodies. On the other hand, it is
important to differentiate those procedures which can be performed in low-complexity health care
centers and those centers where research and development tasks are performed.
Low complexity health care centers
a) In patients under 6 months of age, diagnosis should be exclusively made through the presence of
parasites in blood. We recommend the microhematocrit (MH) technique, its sensitivity depends on the
operator. According to our experience, sensitivity was 93% during the first weeks of life. Serological
tests are not useful due to the presence of maternal antibodies during this period. Every child born of a
serologically reactive mother with negative MH, should undergo serological testing as from the 7
months of life.
b) After the seventh month, diagnosis is confirmed when the patient´s serum presents 2 reactively
different serological techniques (SC), ELISA, IHA, IFI.
High complexity centers
a) Parasitological techniques: both Xeno diagnosis and hemoculture are complex and expensive
techniques. Their advantage is that they are highly sensitive while their disadvantage is that they take
a long time to show results. PCR is still not a validated procedure. Our experience is as follows: in
patients under 6 months of age, sensitivity(S) was 100% and specificity(E) was 97%. In patients over
7 months of age, S was 73.8% and E was 100%. We consider that all these procedures are useful only
for research work.
b) Although many T.cruzi antigens have been assayed for serologic tests, only a few have proved to
be useful. SAPA proposed as an acute infection marker was positive in about 30% of patients infected
during the undetermined stage.
At present we have only one drug, benznidazol for treatment. Suggested dosage is from 5 to 10 mg/
kg/d and duration of treatment varies from 30 to 60 days. Cure criteria is obtaining negative SC in two
successive samples. The cure percentage of 203 children from 1 month old to 15 years of age showed
the following results: a) 100% for patients younger than 3 months, b) 97% for children under 3 year old
and c) 87% out of the total.
The older the patient is at the start of treatment, the longer it takes for negative tests to show. We
have observed that negative testing occurs between three months and eight years after treatment. In
order to shorten this period, we have developed an ELISA using antigen F2/3 obtained from
trypmastigotes (Almeida). The results showed a significant difference (p=0.0025) comparing negative
testing of anti-F2/3 antibodies with antibodies detected by SC in patients older than 8 months of age.
B) Toxoplasmosis
Human infection by T.gondii is very frequent, generally asymptomatic and only in immunodeficient
patients or fetus that suffered acute infection during pregnancy, it can cause diseases of different severity.
Most frequent pediatric patients are children born with congenital infection (CT). Only 40% of children
born from T.gondii infected mothers acquire the infection.
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About 70% of prenatally infected infants are clinically asymptomatic at birth. Clinical findings in
23 infants with CT in our service were: chorioretinitis (82%), retinal detachment (26%), prematurity
(21%), hidrocephalus (43%), microcephaly (43%), hepatomegaly (34%).
Parasitological diagnosis is expensive and has low sensitivity. The PCR is not properly standardized
and shows false negatives and positives.
In the medical practice, diagnosis is made by evaluating specific antibodies to IgG, IgA and IgM.
The most frequently used technique is ELISA, which uses different antigens. Other techniques are
IHA and IFI.
The presence of maternal IgG in the newborn delays diagnosis in the first months of life. The
detection of anti-T.gondii IgG after 8 months is the gold standard to diagnose CT. IgM and IgA are
considered markers of CT in a newborn, but the S varies among authors. Table 1 shows our results.
Treatment of CT results in a more favorable outcome, the sooner the therapy is given, the better the
results are. Unfortunately, many infants receive treatment, therefore we are not sure if they are infected.
We tested some recombinant antigens (rRop2, rGra4, rGra7) with Dr Sergio Angel, (INTECH, Buenos
Aires) in order to improve the diagnosis, at least to verify whether infants born from infected mothers
are not infected. Table 2 shows the results in the follow-up of 59 infants and their mothers at risk of CT.
Antidodies against recombinant antigens became negative earlier than antibodies detected by
conventional serology in the follow-up of not infected infants.
Table 1. CS analysis of the first serum samples from all infected and non infected ifants and their
mothers
IgG +/n (%) IgM +/n (%) IgA +/n (%) IgM/IgA +/n (%)
Infected
Mother 18/18 (100) 10/18 (55) 6/18 (33) 11/18 (61)
Newborn 23/23 (100) 15/23 (65) 17/23 (74) 19/23 (83)
Non Infected
Mother 27/27 (100) 7/27 (26) 2/27 (7) 7/27 (26)
Newborn 36/36 (100) 3/36 (8) 3/36 (8) 5/36 (14)
Table 2. Negativization age of non-infected infants by using commercial (c)-, rRop2-, rGra4- and
rGra7-ELISA
Technique Average of Confidential limit p value vs cELISA
negativization age+ (CI) 95% range (p<)
CELISA 5.88 5.1 – 6.6 NC
rRop2* 3.43 2.6 – 4.3 0.05
rGra4 2.08 1.4 – 2.8 0.001
rGra7* 0.99 0.6 – 1.4 0.001
NC, not corresponding; +, in months; * p<0.001 between them
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MCCT2 - GLYCOLIPID ANTIGENS OF LEISHMANIA AND TRYPANOSOMA
CRUZI AS POTENTIAL TARGETS TO CHEMOTHERAPY
Helio K. Takahashi and Anita H. Straus
Departament of Biochemistry, Section of Glycoconjugate Immunochemistry, Universidade Pederal de São Paulo/
EPM
Leishmania is an intracellular parasite, and macrophages are its primary targeted host cell. Contrasting
with the number of information available regarding the phagocytic processes of promastigote forms,
few works in this area have been carried out with amastigotes, forms responsible for maintaining and
disseminating the infection in the vertebrate host. In L. (L.) amazonensis amastigotes, glycosphingolipid
(GSL) antigens were first described by Straus et al. (1) and shown to be related to macrophage invasion.
Seventeen different neutral GSL antigens were identified by their reactivities with monoclonal antibodies
(mAbs) ST-3, ST-4 and ST-5, directed to carbohydrate moieties of GSLs, and the chemical quantity of
these antigenic GSLs would account for 1x106 molecules/cell. The structure of the smallest GSL antigen
was elucidated by 1H NMR, GC/MS and use of exoglycosidase as: Galβ1-3Galα1-3-Galβ1-4Glcβ1-
1Cer (henceforth referred to as β-Gal-globotriaosylceramide). The chemical quantity of β-Gal-
globotriaosylceramide was estimated in 2x105 molecules/cell.
Studies carried out in our lab, focusing in the biological roles of glycolipid antigens, demonstrated
that the terminal β-Gal residue of L. (L.) amazonensis amastigote stage-specific glycosphingolipid
antigens is a key component of the epitope recognized by the mAb ST-3. By in vitro assays 70-80%
inhibition of macrophage invasion/binding by amastigotes of L. (L.) amazonensis was obtained with
mAb ST-3. In vivo infectivity assays using amastigotes pre-incubated with either Fab fragments or
intact antibody showed a delay in the development of BALB/c mice footpad lesions. The definitely
evidence of the direct involvement of GSLs presenting β-Galp in parasite-macrophage interaction was
demonstrated by the observation that addition of the disaccharide Galpb1-3Galp (1mM) was able to
inhibit about 48% of macrophage monolayers infectivity by amastigotes.
Thus, in order to identify the macrophage molecules involved in the L. (L.) amazonensis amastigote
GSLs recognition, it was examined the binding of micelles prepared using amastigote purified GSLs to
blots of the macrophage membrane lysate isolated from culture of mouse resident peritoneal
macrophages. The micelles binding were probed using mAbs directed to parasite GSLs, it was observed
that micelles containing L. (L.) amazonensis amastigote purified GSL fractions, bound strongly to a 30
kDa molecule. These results show that macrophage monolayers express a (glyco)protein able to
recognize amastigote GSLs. In order to discard the possibility that glycosphingolipids containing one
(CMH), two (CDH) or three (CTH) residues of carbohydrate, present in the amastigote GSLs fraction
could be the responsible for this binding, a fraction containing only GSLs not reactive with mAb ST-3
(CMH, CDH, and CTH) were used to prepare micelles. Pre-incubation of micelles presenting CMH,
CDH, and CTH with the nitrocellulose membrane did not interfere on the binding of micelles prepared
with amastigote purified GSLs containing more complex carbohydrate chains reactive with mAb ST-3.
As shown before these GSLs are present in the parasite surface, therefore instead of using GSLs micelles,
a more biological assay was carried out using fixed amastigotes, and it was confirmed that the parasites
were also able to bind to the 30 kDa (glyco)protein.
On the other hand, Leishmania (Leishmania) major do not express GSLs, but they express
glycosylinositol phospholipids (GIPLs). Recently we demonstrated the role of glycosylinositol
phospholipid-1 (GIPL-1) of L. (L.) major in interaction of promastigotes and amastigotes with
macrophages. A mAb MEST-1 that recognizes glycolipids containing terminal galactofuranose (galf)
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residue (2) was used to detect GIPL-1 in Leishmania by indirect immunofluorescence, and to analyze
its role in macrophage infectivity. L. (L.) major promastigotes showed intense fluorescence with MEST-
1, and GIPL-1 was detected in both amastigote and promastigote forms by HPTLC immunostaining
using MEST-1. Delipidation of L. (L.) major promastigotes with isopropanol/hexane/water abolished
the MEST-1 reactivity, confirming that only GIPL-1 is recognized in either amastigotes or promastigotes
of this specie. The role of GIPL-1 and its galf residue in the processes of binding and invasion of
macrophage monolayers was analyzed by pre-incubating parasites with MEST-1 Fab fragments, which
reduced macrophage infectivity by ~80% for promastigotes and 30% for amastigotes. The more modest
inhibition of amastigotes adhesion than for promastigotes, could be due to GIPL-1 crypticity in
amastigotes or due to a lower GIPL-1 concentration in amastigotes than promastigotes, as observed by
immunofluorescence. The substantial inhibition (~80%) of macrophage infectivity by promastigotes
in the presence of p-nitrophenyl-β-D-galactofuranoside confirmed the importance of terminal β-D-
galf residue. Significant inhibition (~65%) of macrophage infectivity was also observed when p-
nitrophenyl-α-D-mannopyranoside was used, indicating involvement of a mannose receptor in
Leishmania-macrophage interaction. No inhibition was observed when macrophages were preincubated
with p-nitrophenyl-β-D-galactopyranoside. Cell-cell interactions and attachment processes are multi-
step phenomena, and the present results indicate that one such receptor recognizes terminal residues of
galf. The receptor for terminal galf residues in glycoconjugates of parasites and fungi is yet
uncharacterized, but currently under investigation. Tsuji et al. (3) recently identified a new type of
human lectin, termed human intelectin (hIntL), which binds to pentoses and to D-galf residue in the
presence of Ca2+. A recombinant hIntL recognizes bacterial arabinogalactan of Nocardia containing D-
galf, thus, this lectin may be involved in recognition of various pathogens containing galf residues, e.g.,
Nocardia, Mycobacteria, Streptococcus, Leishmania and Trypanosoma. The present results suggest
that terminal residues of β-D- galf present in GIPL-1 from either promastigote or amastigote forms of
L. (L.) major are recognized by a previously undescribed macrophage receptor involved in Leishmania-
macrophage interaction.
Other glycoconjugates containing galactofuranose residues also have been described in fungi,
bacteria, and trypanosomatides such as Trypanosoma cruzi and Leishmania (2, 4-6). Although the
biological role of Galf residues remains to be completely ascertained, the postulated absence of Galf
and galactofuranosidases in mammalian species suggests the intriguing hypothesis that terminal Galf
residues play a central role in survival of fungi and parasites by preventing the action of the host’s
glycosidases on their glycoconjugates. If this hypothesis is correct, Galf residues are potentially useful
as specific target molecules for therapy of parasitic diseases.
A lipopeptidophosphoglycan currently termed glycoinositol phosphoceramide (GIPC) has been
described as the major glycoconjugate of the T. cruzi epimastigotes. T. cruzi GIPCs present well known
carbohydrate structures containing one or two terminal Galf residues (7,8). By indirect
immunofluorescence it was demonstrated that mAb MEST-1 also recognizes T. cruzi epimastigotes
and amastigotes, showing no/weak reactivity with trypomastigotes. Using different immunochemistry
assays, it was verified that the antigens recognized by MEST-1 in these parasites are glycolipids and
that the expression of these glycoconjugates varies as differentiation of amastigotes into trypomastigotes
occurs, as noticed by the decrease of the MEST-1 reactivity with trypomastigotes. The glycolipid
antigens labeled with MEST-1 are localized in epimastigotes on internal acidic structures (reservosomes),
which are also stained with Lysotracker Red. In contrast, for amastigote forms, it was detected a strong
fluorescence on the parasite surface, suggesting that GIPCs synthesis may be important for the
intracellular amastigotes survival and division (9). Although there is no report about the efficacy of
inhibitors of inositol phosphorylceramide (IPC) synthase in trypanosomatids, the effect of IPC synthase
inhibitors in other organisms is well know, such as in Aspergillus fumigatus and Aspergillus nidulans,
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and these drugs are prime candidates for a more effective chemotherapy in deep mycosis (10). The data
shown here indicates that search for efficient and highly specific inhibitors of galactofuranosyl,
β-galactosyl transferases and IPC synthase of Leishmania and T. cruzi may represent a viable strategy
for design new drugs for the chemotherapy of these major parasitic diseases.
Supported by: FAPESP and CNPq
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MCE1 - UNDERSTANDING THE GEOGRAPHY OF DISEASE TRANSMISSION
USING ECOLOGICAL NICHE MODELING
Peterson, A. T.
University of Kansas Natural History Museum and Biodiversity Research Center, Lawrence, Kansas.
Disease transmission cycles can be seen as interacting sets of species that themselves interact with
their environments in space and time. Ecological niche modeling (ENM) is a relatively new technique
that uses known occurrences and GIS data sets to produce a predictive model of ecological niche
dimensions. Using ENM, it is thus possible to reconstruct and predict geographic aspects of disease
transmission cycles, based on species-specific ecological niche models. I illustrate the potential of this
approach using examples from Chagas disease, leishmaniasis, West Nile virus, malaria, and ebola.
MCE2 - THE RAT SAT ON THE CAT: THE MANIPULATION OF HOST
BEHAVIOUR BY TOXOPLASMA GONDII.
Joanne P. Webster
According to the Manipulation Hypothesis, a parasite may be able to alter the behaviour of a host
for its own selective benefit, usually by enhancing its transmission rate. Classic examples concern
transmission through the food chain, where a parasite is immature in the intermediate host, which must
be eaten by a predatory definitive host before the parasite can reach maturity and complete its life-
cycle. The parasite thus manipulates the behaviour of its intermediate host so as to ensure its transmission
to the correct definitive host. Toxoplasma gondii, the causative agent of toxoplasmosis, is one such
indirectly-transmitted parasite suggested to achieve such manipulation. Whilst it was traditionally
believed that latent toxoplasmosis is asymptomatic and of no clinical or epidemiological interest within
immunocompetent human or animal hosts, recent evidence now suggests this in unlikely to be true.
Studies within naturally and experimentally infected rodents indicate that T. gondii can enhance the
likelihood of predation by the feline definitive host through the subtle manipulation of intermediate
host behaviour: infected rats are significant more active, more exploratory and less fearful of novel
stimuli in their environment, and even show an attraction to areas indicative of predator presence.
Moreover, this attraction towards areas of predator presence appears specific to only that of the feline
definitive host, where infected rats continue to avoid non-feline predators such as mink. All behavioural
traits and health indices unlikely to influence predation rate by the feline definitive host remain intact.
A number of recent studies have also detected behavioural alterations within latently infected humans
similar to those observed within rodents. Of current concern is a potential relationship between T.
gondii infection in humans and some instances of first incidence psychosis or schizophrenia. Support
for such a link is provided, in part, by the shared anti-protozoan properties of successful anti-
schizophrenic drugs. The role of such chemotherapy on the development and maintenance of T. gondii
induced behavioural alterations in its rodent intermediate host stage is also presented here, and the
results discussed in terms of their theoretical and applied implications.
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MCIM1 - THE TRYPANOSOMA CRUZI PROLINE RACEMASE : AN ENZYME
WITH MULTIPLE ROLES - FROM DEVELOPMENT TO PARASITE ESCAPE.
Paola Minoprio, and collaborators*
Department of Immunology, Institut Pasteur, 25 rue du Dr. Roux, 75724 Paris, France
We have previously proposed that mitogens and superantigens, moieties that are essential components
of micro-organisms can be responsible for the initiation of nonspecific polyclonal lymphocyte activation
and this, per se, may explain the strategy used by pathogens to avoid the host immune responses and to
ensure persistence. We had shown that metacyclic infective forms of T. cruzi do secrete molecules
responsible for such a mechanism of immune evasion. Using biochemical and molecular approaches
we isolated from the supernatants of metacyclic cultures, a parasite protein involved in the polyclonal
activation of B lymphocytes. This protein is the first eukaryotic proline racemase, TcPRAC, previously
annotated as TcPA45, for Trypanosoma cruzi polyclonal activator of 45 kDa. By the analysis of the
genomic organization and transcription of TcPRAC gene we showed the presence of two homologous
genes (TcPRACA and TcPRACB) per parasite haploid genome. These two genes are located in two
different chromosomal bands of which one contains more than 3 chromosomes of similar size. TcPRAC
mRNA is differentially transcribed in the different parasite stages. In fact, we showed that the parasite
can differentially express intracellular and secreted isoforms of the TcPRAC protein, respectively of
39 kDa in epimastigote (non-infective) forms of the parasite and of 45 kDa in metacyclic (infective)
forms. The mapping of the 5’ region of the transcribed genes during parasite development allowed us
to demonstrate that both TcPRACA and TcPRACB transcripts are present in all parasite stages.
Furthermore, we confirmed that although TcPRACB gene by itself only encodes the intracellular version
of the protein and that trans-splicing signals embedded within TcPRACA paralogue enable the gene to
generate both cytoplasmic and secreted isoforms of TcPRAC by alternative trans-splicing mechanism.
We then produced two recombinant isoforms of the TcPRAC protein by overexpressing TcPRACA or
TcPRACB paralogous genes in E. coli and purified the 45kDa and 39kDa isoforms of the protein
tagged at the C terminus by a polyhistidine tail. By biochemical assays we showed that TcPRACA and
TcPRACB isoforms do indeed posses proline racemase activities racemizing both L- and D- proline
and no other amino acid. This activity is co-factor independent and closely resembles that of the proline
racemase of the protobacterium C. sticklandii (CsPRAC). Biochemical studies revealed that both




 values, specific buffer and pH requirements that are compatible
with the enzyme being functional in either internal or external cellular compartments. However, assays
with pyrrole-2-carboxylic acid (PAC), the specific and competitive inhibitor of proline racemase, revealed
that PAC is relatively effective (in the micromolar range) in inhibiting both enzymes. Western blot
analysis using total or cytosolic extracts from non-infective (epimastigote) and infective (metacyclic)
forms of the parasite, and the corresponding culture media, confirmed that TcPRACA and TcPRACB
paralogous genes are functional in vivo since both intracellular (39 kDa) and the secreted (45 kDa)
isoforms display proline racemase activities. By in vitro and in vivo proliferation assays we showed
that TcPRACA, the parasite secreted proline racemase, is a T-cell independent B-cell mitogen. Moreover,
the TcPRACA mitogenic activity is abolished, or severely compromised whenever enzymatic activity
is inhibited by specific inhibitors or substrate excess. Furthermore, we showed that B-cell triggering
depends on conformational epitopes of TcPRACA rather than on the proline racemase activity (see M.
Goytia and coll, in these proceedings). Crystallography of TcPRACA clearly showed that saturation of
TcPRACA by its specific inhibitor (PAC) induces a conformational change in the protein and that any
direct interaction of TcPRACA with a membrane B-cell receptor (postulated for the polyclonal B cell
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activation) is unambiguously dependent on conformational epitopes displayed by the protein. To better
approach the biological relevance of proline racemases in the metabolism of T. cruzi, and consequently
the influence of the enzyme on parasite differentiation, we over-expressed TcPRACA and TcPRACB
paralogue genes in non-infective parasite forms using appropriate vectors to obtain stable chromosomal
integration of these genes (in sense and antisense orientationsas verified by chromoblots). The first
important observation was that non-infective forms of the parasite expressing full length antisense
TcPRACB RNA (functional knock outs, KO) are not viable whereas functional TcPRACA-KO survive
only poorly even under low selection pressure for recombinant parasites. We also determined that
TcPRAC enzymes are differentially involved in metacyclogenesis and that fully differentiated metacyclic
parasites over-expressing TcPRAC genes were more virulent to host cells, as ascertained by invasion
and release of the parasites in host cell co-cultures. These data showed that TcPRACA proline racemase
is both a mitogen and a virulence factor. Since we observed an important conservation of critical
residues between TcPRAC we then used available databases (SWISS-PROT and TrEMBL to define a
minimal motif (Motif III), (DRSPCGX[GA]XXAXXA), sufficiently conserved to yield several predicted
protein sequences with high similarity to proline racemases from 9-12 organisms including organisms
of medical importance (i.e. Bacillus anthracis, Brucella suis, Clostridium botulinum, Aspergillus
fumigatus, Leishmania (L.) major, Trypanosoma brucei, amongst others, but not Plasmodium) suggesting
that proline racemases are widespread but not ubiquitous in more complex organisms. Biochemical
and functional characterization of these putative proline racemases are in progress.
This work was supported by Institut Pasteur and CNRS, URA 1960-1961.
* A B-cell mitogen from a pathogenic trypanosome is a eukaryotic proline-racemase. B. Reina San Martin, W. Degrave, C.
Rougeot, A. Cosson, N. Chamond, A. Cordeiro da Silva, M. Arala-Chaves, A. Coutinho and P. Minoprio. Nature Medicine
6 : 890-897, 2000
* Biochemical and characterisation of proline racemases from the human protozoan parasite Trypanosoma cruzi and definition
of putative protein signatures. N. Chamond, C. Grégoire, N. Coatnoan, C. Rougeot, L.H. Freitas Junior, J. F. da Silveira,
W. Degrave and P. Minoprio. J. Biol. Chem. 278 : 15484-15494, 2003.
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MCIM2 - THE ROLE OF APOPTOTIC MIMICRY IN HOST- PARASITE
INTERPLAY
Marcello A. Barcinski 1, 2, *, Maria Elisabete Costa Moreira 2, José Mario de Freitas Balanco 1, João Luiz M.
Wanderley 2, 3 and Adriana C. Bonomo 2 ,3
1. Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo. 2. Division of
Experimental Medicine, National Cancer Institute. 3. Institute of Microbiology, Federal University of Rio de
Janeiro
Multicellular organisms can clearly benefit from the non-inflammatory elimination by apoptosis of
unnecessary and potentially harmful cells. Recently accumulated data show that unicellular organisms
such as pathogenic trypanosomatids can also take advantage of different apoptotic features. Examples
are the capacity of Trypanosoma cruzi and Leishmania spp to take advantage of different features of
the apoptotic process to establish a host-parasite relationship, without death as the necessary outcome.
Indeed, we have described that amastigotes of Leishmania (L.) amazonensis display phosphatidylserine
(PS) on the outer leaflet of their cellular membrane. This molecular moiety induces an anti-inflammatory
response of the macrophages through the activation of a specific receptor. Macrophages are the obligatory
habitat of Leishmania spp. in the mammalian hosts and, paradoxically, are also the effector leishmanicidal
cells when properly stimulated by the adaptive immune response of the host . The PS-dependent anti-
inflammatory response is characterized by inhibition of nitric oxide synthesis and activation of TGFß
and IL-10 production; the net result is an increase in internalization and a facilitated intramacrophagic
proliferation of the parasite (1). PS exposure is one of the most precocious and widespread features of
a cell primed for apoptosis; it is essential for the non-inflammatory disposal of dying cells and thus
allows apoptosis to occur without disturbing normal organogenesis and normal adult cell renewal. This
same feature, in an apoptotic-mimicry fashion, seems to be important for the establishment of Leishmania
spp as an obligatory intramacrophagic parasite of mammalian hosts. Interestingly, Trypanosoma cruzi,
a parasite displaying just a transient intramacrophagic phase in the vertebrate host, is endowed with the
capacity of inducing apoptosis in the host’s T lymphocytes [2]. This parasite, which displays only
traces of PS in its lipid composition, takes advantage of the interaction with the macrophages of the PS
exposed by the T lymphocytes, in a very similar way to what Leishmania (L.) amazonensis does with
PS on its own surface. PS exposure can be thus viewed as an important phenotype for the establishment
and maintenance of the present day Leishmania/host relationship. In spite of the fact that the PS-
exposing amastigotes are endowed with the capacity of undergoing typical apoptotic oligonucleosomal
DNA cleavage, the question of whether PS exposure by the parasite is an independent phenomenon or
is part of the molecular demands of a fully operational cell death program remains unanswered. This,
and several other related questions will be discussed in this presentation. First, we still have no clear-
cut evidence whether the PS in the parasite’s surface is synthesized by the parasite itself, or is derived
from the host. The following are strong evidence indicating that the former is the case: (a) axenically
grown metacyclic promastigotes expose PS; (b) plasma membrane translocases, which are capable of
regulating PS exposure, have been described in promastigotes of Leishmania (L.) tropica [3]; and (c)
amastigotes derived from susceptible BALB/c mice systematically expose more PS on their outer
surface than amastigotes derived from resistant C57Bl/6 mice (manuscript in preparation). This fact
induces important differential behavior regarding in vivo and in vitro infectivity of amastigotes derived
from the two different strains of mice. Finally, and central to the present discussion, it is not clear either
if the PS-exposing parasites are the truly infective forms, or if they only contribute to infectivity due to
their PS-depended macrophage inactivation properties. If, indeed, PS exposure is part of a cell death
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program, and the PS positive parasites are the infective ones, they must be rescued from death within
the phagolysosomal environment. If, on the contrary, the infective forms are the PS negative ones, with
the PS positive forms facilitating infectivity, a truly cooperative system is operating here. In both
situations, however, PS exposure, with its consequent macrophage inactivation, is the relevant phenotype
for parasite persistence in the host. Parasite death by apoptosis is, in the present situation, just a side
effect.
References:
1. Balanco JMF, Costa Moreira ME, Bonomo A, Bozza PT, Amarante-Mendes G, Pirmez C, Barcinski MA: Apoptotic
mimicry by an obligate intracellular parasite downregulates macrophage microbicidal activity. Current Biology 2001, 11:
1870-1873
2. Freire de Lima CG, Nascimento DO, Soares MB, de Mello FG, Bozza PT, Castro Faria Neto HC, Dos Reis GA, Lopes
MF: Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages Nature 2000, 403: 199-203
3. Tripathi A, Gupta CM: Transbilayer translocation of membrane phosphatidylserine and its role in macrophage invasion in
Leishmania promastigotes. Molecular & Biochemical Parasitology 2003, 128: 1-9
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MCMB1 - WIDESPREAD OPERONS IN THE C. ELEGANS GENOME: WHY AND
HOW
Tom Blumenthal
Department of Biochemistry and Molecular Genetics, University of Colrado School of Medicine, Denver, CO
USA
Unlike other animals but similar in some ways to trypanosomes, C. elegans and its relatives have
polycistronic transcription units. These operons resemble bacterial operons. We analyzed theC. elegans
genome to investigate which genes are contained in operons (Blumenthal et al., 2002, Nature 417:851),
and determined that more than 15% are in operons. These multi-gene assemblages range from 2 to 8
genes in length and can extend over 50 kb. We have analyzed the list of ~1000 operons, containing
~2,600 genes, to determine what types of genes they contain and whether functionally related genes
are co-transcribed in operons.
Some classes of genes are highly represented in operons, especially mitochondrial genes and the
genes for the basic transcription, splicing and translation machinery. In general, genes whose mRNAs
are enriched in the female germ line have the strongest tendency to be contained in operons. In contrast,
genes that are highly regulated in a particular tissue are generally excluded from operons. Examples
are genes for transcriptional activators, collagens, sperm proteins, intermediate filament proteins,
cytochrome P450s, immunoglobulin domain proteins and basement membrane proteins.
Many operons encode two or more functionally related proteins. Recently, genes related to a gene
of interest have been identified by their presence together in a C. elegans operon. The operon list
suggests many unsuspected relationships among proteins, but whether most operons contain functionally
related genes is not yet known.
The worm operons are processed much like trypanosome polycistronic transcripts. RNA polymerase
makes a multicistronic pre-mRNA that is processed by cotranscriptional 3’ end formation and trans-
splicing . In C. elegans there are two spliced leader RNAs (the donor in trans-splicing). SL1 is used at
5’ ends of most genes, just to trim off the outron, the sequence between the promoter and the trans-
splice site. SL2 is specialized for use at trans-splice sites between genes in operons. 3’ end formation
generally occurs about 100 bp upstream of operon trans-splice sites, but unlike in trypanosomes, it is
not dependent on trans-splicing or on the polypyrimidine tract used for trans-splicing. Instead, it is
signaled by the conventional AAUAAA and GU rich signals that bind CPSF and CstF, as in mammals,
and 3’ end formation precedes trans-splicing.
We have identified the key signal between genes that results in efficient SL2-specific trans-splicing.
It is a U-rich sequence, the Ur element, that is very likely to be the site at which CstF binds to facilitate
3’ end formation as well. We have shown that CstF binds to the SL2 snRNP and this binding strongly
correlates with function. Binding of protein to the Ur element serves two separable purposes. First, it
blocks the progress of an exonuclease that gains entry to the pre-mRNA due to 3’ end formation just
upstream. Second, it attracts the SL2 snRNP. Preliminary evidence will be presented for a protein that
is specific to the SL2 snRNP that appears to be responsible for this interaction.
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MCMB2 - MOLECULAR BASIS OF CHLOROQUINE RESISTANCE IN
PLASMODIUM VIVAX MALARIA.
Juliana Martha Sá, Marcio Massao Yamamoto, Emilio Fernando Merino, Carmen Fernandez-Becerra and Hernando
A del Portillo (hernando@icb.usp.br).
Departamento de Parasitologia (ICB), Universidade de São Paulo, Brazil.
Plasmodium vivax is the most widely distributed human malaria and responsible for 70-80 million
clinical cases each year and large socio-economical burdens for countries such as Brazil where it is the
most prevalent species. Unfortunately, due to the impossibility of growing this parasite in continuous
in vitro culture and the low parasitemias obtained directly from infected patients, research on P. vivax
remains largely neglected. We have therefore undertaken a genomics approach to study this human
malaria by constructing a genomic library in yeast artificial chromosomes from which to obtain unlimited
parasite material (Camargo AA, Fischer K, Lanzer M & del Portillo HA. 1997. Genomics, 42:467).
Chloroquine (CQ) has been the drug of choice for eliminating P. vivax infections but resistance has
been an increasing problem since it was first reported from Papua New Guinea in the late 80’s. In fact,
the geographic distribution of CQ resistance (CQR) in P. vivax has now extended to India, Myanmar,
Guyana and Brazil. The gene putatively responsible for CQR resistance in P. vivax, pvcg10, has been
recently identified and mapped with the aid of the P. vivax YAC library (Nomura T, et al. 2001. J. Inf.
Dis. 183:1653). Significantly, unlike its orthologous gene in P. falciparum, pvcg10 mutations are not
associated with CQR suggesting that CQR in P. vivax could be associated with expression levels
adjustments or another yet to be discovered mechanism. We have thus generated transgenic lines of P.
falciparum expressing pvcg10 at different levels in order to determine whether a high expression of
this transgene alters the IC50 and the global gene expression of the recipient 3D7 CQ sensitive clone.
Supported by FAPESP and CNPq
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MCVE1 - OLD AND NEW CHALLENGES FACING THE CONTROL OF CHAGAS’
DISEASE IN THE AMERICAS
Antônio Carlos Silveira
Human Chagas’ disease is associated to poverty or to an unprotected relationship between the man
and the vector. This is undoubtedly the primary challenge, which refers to the origin of the disease
production.
Moreover, there are other challenging situations that are not old or new, but related to epidemiology
of the disease, or to its natural history, which limit the possibilities of its control: I) since Chagas’
disease is primarily an enzootics, it is not extinguishable; ii) due to the number of animal hosts, there
is no way to act with the purpose of extinguishing infection sources; iii) at the acute phase, the disease
is unapparent most of the times, which obstructs the detection of the major number of recent infection
cases, when specific chemotherapy is definitely effective. Thus, both primary prevention of natural
transmission and secondary prevention at the precocious pathogenic phase have limitations. In addition,
it is relevant to mention the apparently low power of the available means of control, particularly due to
the inexistence of a vaccine that protects populations under risk, and also due to the absence of pharmacies
that can be used at a large scale. Nevertheless, although the vector is the only factor susceptible to
sanitary procedures — through periodic and systematic use of residual-action pesticides at the infested
houses —, the answer seems to be controlled transmission. This is enabled by some attributes of the
vector: stable populations, low mobility and very slow reposition. Additionally, main vector species
are completely domiciliary.
Even though Chagas’ disease is vulnerable to control policies, in spite of its magnitude and
transcendence, the greatest challenge of all, the oldest and longest one is the low level of priority that
has been given to it. This problem comes from the chronic quality of the disease, from its large and
silent clinical path and from the fact that populations under risk don’t demand or have few opportunities
of requesting services; moreover, they are predominantly rural and not influent or even heard. This is
another challenge, which is the fact that these populations live at the edge of the development in many
regions of Latin America, where poverty remains constant, or even worse.
Environment degradation, and/or predatory exploration of natural spaces, which took place at the
origin of the vectors’ domiciliation, still exists in considerable portions of the American continent as
well.
New challenges result, to a great extent, from environmental changes. In the Amazon region an
increasing number of autochthonous cases have been registered. These cases are almost always attributed
to other means of transmission, derived from different actions, such as oral transmission and extra-
domiciliary vector born transmission, this one related to labor activities, specially “piaçaba” extraction,
main habitat of Rhodnius brethesi. These new strategies of control are not formulated. Rhodnius
pallescens, for instance, is a very particular case in Panama, where it is proved to be an important
vector, even if it doesn’t make colonies inside the houses, because of its presence at palm trees that are
part of the enclosed areas, because of its frequent “visits” to the houses and also because of the very
high rates of this species’ natural infection.
Part of the changes is consequence of the control itself. The elimination of domiciliary species,
such as Triatoma infestans’ in some of the South American countries, brought species that used to be
sylvan or peridomiciliary, like Triatoma rubrovaria, to the south of Brazil. In addition, even partial
control of domiciliary species may have caused the domiciliation of other ones. This is what apparently
may have happened to Panstrongylus lutzi , in substitution of Triatoma brasiliensis, in the northeast of
Brazil. In Central America, the expected goal is the perspective of eliminating Rhodnius prolixus, an
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introduced species, not autochthonous, and there should be awareness to this kind of reality, too.
The greater mobility of human population and the large migration from rural places to urban centers,
which have been happening for the last decades, also imply new challenges. The possibility of passive
dispersion of those vectors that are predominantly associated to humans has increased, and the risk of
transmission by transfusion at non-endemic areas has greatly increased as well.
One final question to be considered is how to uphold epidemiologic vigilance of Chagas’ disease in
situations of minimum infestation and risk, which resulted from the success achieved, with the
interruption of transmission in many areas, especially in some countries of “South Cone” region.
MCVE2 - WOLBACHIA BACTERIAL ENDOSYMBIONTS AS THE TOOLS AND
TARGETS OF DISEASE CONTROL
Mark Taylor
Liverpool School of T ropical Medicine
Wolbachia are intracellular bacterial endosymbionts of arthropods. As a group they show a diverse
range of associations with their hosts, ranging from reproductive parasitism to a strict mutualism in
filarial nematodes. One common feature of Wolbachia is its remarkable ability to influence host
reproduction to facilitate its spread through populations. Wolbachia manipulate reproduction through
parthenogenesis, feminization, male-killing and cytoplasmic incompatibility. Exploiting the ability of
Wolbachia to spread through populations has been proposed as a means of introducing genetic
modifications to pests and vectors of disease. In filarial nematodes, the mutualistic dependence on
Wolbachia has been used in a new approach for the control of filariasis. Antibiotics have been used to
clear the endosymbionts, which leads to an inhibition of larval development, moulting and in adult
female worms a complete block in embryogenesis. The depletion of endosymbionts can also lead to
the eventual death of adult worms, suggesting the bacteria may be essential for their long-term survival.
The first trials using antibiotics against human filariasis have been encouraging, with long-term
sterilization in onchocerciasis and potent macrofilaricidal activity in lymphatic filariasis. Growing
evidence also points towards the bacteria contributing to disease pathogenesis in filariasis. When the
bacteria are released from drug-damaged worms they cause inflammatory reactions associated with
the adverse reactions to chemotherapy. Similar activation of innate inflammation by the bacteria causes
the inflammatory responses that lead to river blindness. The use of antibiotics, in addition to perturbing
the symbiotic relationship, could therefore also eliminate the cause of inflammatory-mediated disease.
